• Mashup Score: 0

    Correspondence to: Nikola Cesarovic, PhD, Department of Health Sciences and Technology, Swiss Federal Institute of Technology, Zurich, Switzerland. Email Department of Mechanical and Process Engineering, University and ETH Zurich, Switzerland (J.L.C.). ARTORG Center for Biomedical Engineering Research, University of Bern, Switzerland (Y.R., D.O.). ARTORG Center for Biomedical Engineering Research, University of Bern, Switzerland (Y.R., D.O.). Deutsches Zentrum für Herz-Kreislaufforschung, Partner Site

    Tweet Tweets with this article
    • Cesarovic & colleagues developed a novel clinically relevant pig model of autologous #coronary #microthrombi-induced #MINOCA. Learn more at https://t.co/MtkDKWGVnN @DominikObrist @nA @ETH_en https://t.co/dpNAjWrAKT

  • Mashup Score: 0

    July 13, 2023 — Elixir Medical, a developer of breakthrough cardiovascular technologies, announced enrollment completion in INFINITY-SWEDEHEART, a prospective, multicenter, single-blind, randomized clinical trial of the DynamX Coronary Bioadaptor System, the first metallic coronary artery implant that adapts to vessel physiology versus the Resolute Onyx Drug-Eluting Stent (DES). DynamX Bioadaptor…

    Tweet Tweets with this article
    • @DAICeditor @ElixirMed Elixir Medical announced enrollment completion in #INFINITY_SWEDEHEART, a prospective, multicenter, single-blind, randomized #clinicaltrial of the #DynamX #Coronary #Bioadaptor System: https://t.co/4nke98IREX

  • Mashup Score: 0

    Coronary computed tomography angiography (CCTA) is cheaper, easier to use and its results are easier to understand than Intravascular ultrasound (IVUS), making it ideal for clinical trials of cardiovascular (and other) drug candidates. Additionally, advances in computing and artificial intelligence (AI) are enabling precise measurement of changes in atherosclerosis disease progression, including…

    Tweet Tweets with this article
    • @DAICeditor @itnEditor @dgsomucla @BudoffMd @the_lundquist #Coronary #computedtomography #angiography is a cheaper, less-invasive alternative to #intravascular #ultrasound in #pharmaceutical clinical trials: https://t.co/vPYf0SuomV

  • Mashup Score: 0

    Privacy OverviewThis website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful. …

    Tweet Tweets with this article
    • 📣 ECC Congress is coming up... this 100% digital edition will take place from June 16th to 17th! ✅ Join in online and share your experience with our experts to increase your knowledge of interventional cardiology ➡️ https://t.co/m58JaUFXcK #ECC2023 #cardiology #coronary https://t.co/O2yoXlxRsS

  • Mashup Score: 1

    This study involving 2 large, community-based, longitudinal, cohort studies whether adding 2 markers—coronary artery calcium score and polygenic risk score—to traditional risk factor–based scores improves predicting coronary heart disease among middle-aged to older adults.

    Tweet Tweets with this article
    • .@NIH_NHLBI-funded: In 2 population-based studies involving 3208 adults aged 45-79 years and of #European ancestry, the coronary artery #calcium score but not the #polygenic risk score improved #coronary #HeartDisease risk discrimination. @HeartDocSadiya https://t.co/ZZLtI8p82u https://t.co/Ah6fQ5s6uH

  • Mashup Score: 1

    Phoenix, AZ— Results from Dynamic Coronary Roadmap for Contrast Reduction (DCR4Contrast), a multi-center prospective, unblinded, randomized controlled trial were presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2023 Scientific Sessions. The trial found that Dynamic Coronary Roadmap (DCR), a percutaneous coronary intervention…

    Tweet Tweets with this article
    • @MyJSCAI @KaulP @DrCindyGrines @Radial_ICG @samirpancholy @kalazizimd @cardioPCImom .@DrJMessenger presents our first #LateBreaking abstract here at #SCAI2023 on #PCI guidance using dynamic #coronary roadmap. Learn more ➡️ https://t.co/yNfrZ5YjCc https://t.co/bg341buM7A

  • Mashup Score: 0

    May 16, 2023 — Henry Ford Health Interventional cardiologists William O’Neill, M.D., and Khaldoon Alaswad, M.D., took a page out of the medical history books by performing a new coronary bypass procedure replicated from one not used in decades to treat a patient living with crippling angina ― a severe symptom of coronary artery disease. Retired painting contractor Fred Casciano, 60, from Traverse…

    Tweet Tweets with this article
    • @DAICeditor @HFHCardioFellow @BillONeillMD @KAlaswadMD Henry Ford Health Interventional cardiologists William O’Neill MD and Khaldoon Alaswad MD performed a new #coronary #bypass procedure replicated from one not used in decades to treat crippling #angina: https://t.co/Vq8QkyXFTt

  • Mashup Score: 0

    May 12, 2023 — The US FDA has granted an Investigational Device Exemption (IDE) approval for Concept Medical Inc’s novel MagicTouch Sirolimus Coated Balloon (SCB) for the treatment of Small Vessels (SV) in coronary arteries.  US FDA, on the 25th of April 2023, granted the third IDE approval for Concept Medical’s Sirolimus Coated Balloon – MagicTouch SCB. Along with this latest IDE approval for…

    Tweet Tweets with this article
    • @DAICeditor @conceptmedicals The #FDA has granted an #InvestigationalDeviceExemption (#IDE) approval for Concept Medical Inc’s novel #MagicTouch #Sirolimus #CoatedBalloon (#SCB) for the treatment of Small Vessels (#SV) in #coronary #arteries: https://t.co/Z419EeI7AP